ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Clorazepate Dipotassium Tablets USPBusiness Wire • 06/22/22
ANI Pharmaceuticals Adopts Veeva Commercial Cloud to Better Support Rare Disease PatientsPRNewsWire • 06/21/22
ANI Pharmaceuticals Announces Consolidation of Manufacturing Network, Capturing Operational Synergies Post Novitium AcquisitionBusiness Wire • 06/02/22
ANI Pharmaceuticals Announces the FDA Approval and Imminent Launch of Fludrocortisone Acetate Tablets USPBusiness Wire • 06/01/22
ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/10/22
ANI Pharmaceuticals (ANIP) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/10/22
ANI Pharmaceuticals Reports First Quarter 2022 Results; Provides Purified Cortrophin® Gel Net Revenue Guidance and Full-Year 2022 Total Company Net Revenue Guidance of $295 Million to $315 MillionBusiness Wire • 05/10/22
ANI Pharmaceuticals to Discuss First Quarter 2022 Financial Results on May 10, 2022Business Wire • 04/19/22
ANI Pharmaceuticals Appoints Experienced Commercial Leader, Renee P. Tannenbaum, Pharm.D.Business Wire • 03/22/22
ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/15/22
ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; Strong Foundation in Place to Drive Sustainable GrowthBusiness Wire • 03/15/22
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022Business Wire • 03/07/22
Oakrum Pharma and ANI Pharmaceuticals Announce the Launch of Betaine Anhydrous Powder, the first Generic Version of Cystadane® (betaine anhydrous for oral solution) Powder, Including 180 Days of ExclusivityPRNewsWire • 02/14/22
ANI Pharmaceuticals Announces Commercial Availability of Purified Cortrophin™ Gel (Repository Corticotropin Injection USP) for Multiple Chronic Autoimmune DisordersBusiness Wire • 01/24/22
ANI Pharmaceuticals to Present at the H.C. Wainwright Bioconnect Virtual ConferenceBusiness Wire • 01/03/22
ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Rifabutin Capsules USPBusiness Wire • 12/21/21
ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Scale of Generics and CDMO BusinessesBusiness Wire • 11/22/21